A Study of Velzatinib Versus Imatinib in People With Gastrointestinal Stromal Tumors (GIST)

Full Title

A Phase 3, Randomized, Multicenter, Open-Label Study of Velzatinib (GSK6042981) versus Imatinib in Participants with Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Ciara Kelly’s office at 646-888-4312.

Protocol
26-354
Phase
Phase III (phase 3)
Investigator
Ciara Kelly
Co-Investigators
Ping Chi
Diseases
Upper Gastrointestinal
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07585266
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description